Clinical Trial

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2024-01-05; most recent amendment 2025-08-11.
Trial Details
NCT Number NCT06208878
Lead Sponsor CRISPR Therapeutics AG
Conditions Hematologic Malignancy, Solid Malignancy
Enrollment 70 participants
Start Date 2023-11-22
Primary Completion 2038-08 (estimated)
Study Completion 2038-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-14